Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 2 |
STJ
St Jude Medical
STJ
|
+$235M |
| 3 |
JPMorgan Chase
JPM
|
+$211M |
| 4 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5651
Companhia Siderúrgica Nacional
SID
$1.31B
| $23K | ﹤0.01% |
7,984
+1,397
| +21% | +$5.08K |
|
5652
Tennant Co
TNC
$1.43B
| $23K | ﹤0.01% |
319
-550
| -63% | -$38.7K |
|
5653
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $23K | ﹤0.01% |
474
-2,898
| -86% | -$135K |
|
5654
PUT
VirnetX Holding Corp
VHC
$54.4M
| $23K | ﹤0.01% |
510
+340
| +200% | +$15.6K |
|
5655
State Street SPDR S&P Pharmaceuticals ETF
XPH
$476M
| $23K | ﹤0.01% |
560
-200,000
| -100% | -$8.15M |
|
|
CTT
5656
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $23K | ﹤0.01% |
2,008
+1,463
| +268% | +$15.8K |
|
|
AMAG
5657
CALL
DELISTED
AMAG Pharmaceuticals
AMAG
| $23K | ﹤0.01% |
1,000
+800
| +400% | +$19.2K |
|
|
SAEX
5658
DELISTED
SAExploration Holdings, Inc.
SAEX
| $23K | ﹤0.01% |
+195
| New | +$23.8K |
|
|
PLPM
5659
DELISTED
Planet Payment, Inc
PLPM
| $23K | ﹤0.01% |
5,655
+4,784
| +549% | +$19.7K |
|
|
UCP
5660
DELISTED
UCP, Inc.
UCP
| $23K | ﹤0.01% |
2,374
+2,314
| +3,857% | +$25.7K |
|
|
GTT
5661
DELISTED
GTT Communications, Inc.
GTT
| $23K | ﹤0.01% |
925
-1,429
| -61% | -$38.8K |
|
|
VVUS
5662
CALL
DELISTED
Vivus Inc
VVUS
| $23K | ﹤0.01% |
2,090
-7,750
| -79% | -$87.7K |
|
5663
Angi Inc
ANGI
$229M
| $22K | ﹤0.01% |
388
-43
| -10% | -$2.73K |
|
5664
CALL
Banner Corp
BANR
$2.39B
| $22K | ﹤0.01% |
400
+200
| +100% | +$11.4K |
|
5665
CALL
Calumet Specialty Products
CLMT
$3.85B
| $22K | ﹤0.01% |
5,900
+1,200
| +26% | +$4.75K |
|
5666
PUT
Coherent
COHR
$51.4B
| $22K | ﹤0.01% |
600
+200
| +50% | +$7.06K |
|
5667
CorVel
CRVL
$3.06B
| $22K | ﹤0.01% |
1,491
+1,038
| +229% | +$13.7K |
|
5668
CALL
Dine Brands
DIN
$456M
| $22K | ﹤0.01% |
400
+100
| +33% | +$6.31K |
|
5669
CALL
Brinker International
EAT
$9.17B
| $22K | ﹤0.01% |
500
| – | – |
|
5670
Fortress Biotech
FBIO
$104M
| $22K | ﹤0.01% |
399
+333
| +505% | +$14.9K |
|
5671
Farmers National Banc Corp
FMNB
$939M
| $22K | ﹤0.01% |
1,497
+1,115
| +292% | +$15.3K |
|
|
JPXN
5672
iShares JPX-Nikkei 400 ETF
JPXN
$134M
| $22K | ﹤0.01% |
390
-2,000
| -84% | -$111K |
|
5673
Republic Bancorp
RBCAA
$1.95B
| $22K | ﹤0.01% |
636
+371
| +140% | +$13.3K |
|
5674
STRATTEC Security
STRT
$367M
| $22K | ﹤0.01% |
816
+767
| +1,565% | +$25.3K |
|
5675
Vicor
VICR
$9.56B
| $22K | ﹤0.01% |
1,391
-408
| -23% | -$6.29K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.